Literature DB >> 12057705

Video-assisted thoracoscopic surgery for primary chylopericardium after orthotopic heart transplantation.

Sandro Gelsomino1, Angelo Morelli, Lorenzo Porreca, Giorgio Morocutti, Paolo Da Col, Ugolino Livi.   

Abstract

Chylopericardium is a rare complication of cardiac surgical procedures. We describe a 41-year-old woman who underwent orthotopic heart transplantation and developed chylopericardium early in the post-operative period. Because of unsuccessful conservative treatment (pericardiocentesis, pericardial drainage, low-fat diet with medium-chain triglycerides, and total parenteral nutrition), surgical intervention was indicated and the patient successfully underwent right-sided thoracoscopic duct ligation and partial pericardiectomy (pericardial window).

Entities:  

Mesh:

Year:  2002        PMID: 12057705     DOI: 10.1016/s1053-2498(01)00380-1

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

1.  Erdheim-Chester disease: The role of video-assisted thoracoscopic surgery in diagnosing and treating cardiac involvement.

Authors:  Aoife Egan; Dan Sorajja; Dawn Jaroszewski; Farouk Mookadam
Journal:  Int J Surg Case Rep       Date:  2011-12-08

2.  Life-Threatening Cardiac Tamponade Secondary to Chylopericardium Following Orthotopic Heart Transplantation-A Case Report.

Authors:  Karol Wierzbicki; Piotr Mazur; Piotr Węgrzyn; Bogusław Kapelak
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-11-06       Impact factor: 1.520

3.  Persistent medical management of chylopericardium following orthotopic heart transplant.

Authors:  E Jackson; A Khan; N Yonan
Journal:  J Surg Case Rep       Date:  2010-08-01

4.  A medical epopee: recurrent fungal endocarditis, heart transplantation and chylopericardium.

Authors:  Antonio de Santis; Guilherme Moratti Gilberto; Sandrigo Mangini; Adalberto Batalha Megale; Fabio Antonio Gaiotto; Ricardo Mingarini Terra; Rodrigo Gobbo Garcia
Journal:  BMC Cardiovasc Disord       Date:  2020-10-31       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.